Laboratory and testing services-IDT:18-012543
Ended Awarded
- Contract number
- HHSN26100003
- Awardee
-
Integrated DNA Technologies, Inc. UEI P55FTN1UMYZ1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,000
Award facts
- Contract value 100% obligated
- $8,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a BPA call valued at $8,000 to Integrated DNA Technologies, Inc. (IDT) on December 15, 2017, for laboratory and testing services (IDT:18-012543). The contract was executed under a Firm Fixed Price arrangement with no set-aside designation, indicating open market competition. Work was performed at IDT's location in Bethesda, Maryland, with an ultimate completion date of January 13, 2018. IDT, headquartered in Coralville, Iowa, is a leading manufacturer of specialized nucleic acid products including custom DNA and RNA oligonucleotides, gene fragments, sequencing products, primers, and probes for federal biomedical research applications.
This award represents a call against an existing Blanket Purchase Agreement, enabling the National Cancer Institute to access IDT's advanced molecular biology technologies and reagents for research initiatives. IDT has established itself as a key commercial supplier to multiple federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Defense, supporting critical research in areas such as genomic sequencing, pandemic response, and precision medicine. The company maintains significant federal contract vehicles, including a $10 million BPA with the National Institute of Neurological Disorders and Stroke and a $5 million BPA with the Defense Health Agency, positioning it as a reliable provider of specialized scientific products and services across the federal government.
Quick answers
Who was awarded contract HHSN26100003?
HHSN26100003 was awarded to Integrated DNA Technologies, Inc. by National Cancer Institute (National Institutes of Health) on December 15, 2017.
How much is contract HHSN26100003 worth?
The government has obligated $8,000 on HHSN26100003.
Is contract HHSN26100003 an order under another contract?
Yes. HHSN26100003 is a BPA call under HHSN263201500214B, a blanket purchase agreement.
Was contract HHSN26100003 competed?
The extent of competition for HHSN26100003 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award